ArticleMedicine2026
Associated factors and a prognostic model for 28-day mortality in Staphylococcus aureus bloodstream infection: A retrospective cohort study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study aimed to identify factors associated with Staphylococcus aureus bloodstream infection (S aureus BSI), compare 28-day survival after propensity score matching (PSM), and develop a prognostic model for 28-day mortality. Adult intensive care unit patients with culture-confirmed BSI were identified in Medical Information Mart for Intensive Care IV. Factors associated with S aureus BSI were assessed in the full cohort by univariable logistic regression. Patients with S aureus and non-S aureus BSI were matched 1:1 using nearest-neighbor PSM without a caliper. Survival was examined using Kaplan-Meier analysis and Cox models with matched-pair cluster-robust standard errors. Among patients with S aureus BSI, prognostic variables were screened by clinical domain and best-subset selection using minimum Bayesian Information Criterion; 10-fold cross-validated least absolute shrinkage and selection operator regression served as a sensitivity analysis. Model performance was assessed by bootstrap internal validation and refitting in an external cohort. The cohort included 2221 patients, including 297 with S aureus BSI. Shorter time from admission to confirmed BSI, absence of tumor, shorter invasive ventilation and vascular catheterization, and fewer antibiotic types before BSI were associated with S aureus BSI. After 1:1 PSM, 28-day mortality was 26.9% versus 24.2%, with no significant survival difference (hazard ratio 1.11, 95% confidence interval 0.80-1.53; P = .539). The prognostic model included age, maximum red cell distribution width, minimum white blood cell count, minimum activated partial thromboplastin time, and maximum albumin. The apparent C-statistic was 0.816 (95% confidence interval 0.757-0.870), and the optimism-corrected C-statistic was 0.804 (95% confidence interval 0.752-0.861). After refitting in 32 external-cohort patients, the same 5 predictors yielded an apparent C-statistic of 0.778 (95% confidence interval 0.591-0.929). S aureus BSI was associated with a distinct prediagnosis profile, but pathogen group was not associated with 28-day survival after matching. The 5-variable model showed good optimism-corrected discrimination. The original prediction equation requires validation in larger external cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.